|Day Low/High||137.32 / 138.28|
|52 Wk Low/High||98.09 / 141.10|
As mentioned earlier, breadth was only 2-1 positive with UnitedHealth , JPMorgan and Johnson & Johnson responsible for a large portion of the market's gains. Bond yields rose, aiding the rate-sensitive banks (who generally met expectations). FANG ha...
"Only" about 2-1 advancers over decliners as UnitedHealth Care , JP Morgan and Johnson & Johnson account for a disproportionate amount of the market's rally.
Of course, performance matters, but investors are forward looking. For this name, this is especially true.
China trade issue is no longer dominating the action.
Many stocks have been in a bear market and certain sectors -- like biotechnology, recent IPOs and oil -- have been under extreme pressure.
Citigroup and Lululemon are on the radar this morning.
Tomorrow morning we have several financials reporting their quarterly results before the market open: Charles Schwab Citigroup Goldman Sachs JP Morgan Chase Wells Fargo What I've noticed is expectations for both Goldman as well as Morgan Stanley , w...
As we get ready to transition into Monday afternoon, investor attention will no doubt begin to focus on the earnings gauntlet of about 160 company reports to be had between Tuesday through Friday. Those reports will include 52 of the S&P 500 compani...
After all the fuss about the latest round of U.S./China trade talks, all that came out was the U.S. has agreed to postpone an increase of tariffs and that China would purchase more U.S. agricultural products.
When things are going well it is always difficult to see an inflection point.
Plus, a look at the uncertain prospects for a Saudi Aramco initial public offering.
"The difference between a politician and a statesman is that a politician thinks about the next election while the statesman thinks about the next generation." --James Freeman Clarke It is good to be sitting for Doug Kass here on this Friday. Hopefu...
Ingredion recently inched up its new quarterly dividend, and while the nation's corn production woes may cause a headwind for the company, its ample cash offers security.
My overall market posture has been one of leaning toward the defensive. I have no intention of making this stance permanent.
Lower interest rates has already been priced into the markets, and these 3 stocks report next week.
* Scharf is a great "get" for Wells Fargo * I expect the long standing underperformance of the bank will soon be a thing of the past * While absolute EPS growth will likely be lackluster over the next 12 months, my analysis argues for the resumption...
Citigroup, JPMorgan Chase and Financial Select Sector SPDR make for a trio of potential long trades to monitor.
Perhaps the greatest risk of all is that of systemic complexity, and this is as close to an unknowable risk as there is.
When you have an oversold market you've got a true coiled spring that can rally beyond where it might ordinary go on good news.
New York Community Bancorp is a regional bank with a 5.4% dividend yield -- far higher than the average bank stock.
There is also reason to see longer-term equity strength in valuations.
Does the Fed just keep injecting liquidity into money markets every single night forever?
You can't have the banks and financial tech stocks go up, old and new tech rally simultaneously and the soft goods companies and industrial techs rise -- someone's wrong.
A market repricing...which are the 'true' growth stocks now?
Should competitors act in a way that puts the U.S. economy at a disadvantage, then by all means the FOMC must act with a level of anger that intimidates.
Market participants are beginning to recognize that there's no stopping the avalanche in selling of the expensive stocks to buy the cheaper stocks like AT&T.
There's apparently no key man risk at Burlington.
Own, but don't buy yet, Dollar Tree and Darden Restaurants.
Lower rates are terrible unless you spend money, buy goods, create businesses, refinance loans and basically exist in America.